Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

treatment outcomes

  • Open Access
    Evaluation of Five Prognostic Scores in Patients Receiving Chemoradiation for Primary Glioblastoma Multiforme
    OKSANA ZEMSKOVA, NATHAN Y. YU, ANASTASSIA LÖSER, JAN LEPPERT and DIRK RADES
    In Vivo July 2024, 38 (4) 1806-1813; DOI: https://doi.org/10.21873/invivo.13632
  • You have access
    Associations Between Time to Treatment Start and Survival in Patients With Lung Cancer
    TRINE STOKSTAD, SVEINUNG SØRHAUG, TORE AMUNDSEN and BJØRN H. GRØNBERG
    In Vivo May 2021, 35 (3) 1595-1603; DOI: https://doi.org/10.21873/invivo.12416
  • You have access
    Rotating Gamma System Irradiation: A Promising Treatment for Low-grade Brainstem Gliomas
    PHAM CAM PHUONG, NGUYEN QUANG HUNG, TRAN BAO NGOC, DIRK RADES and MAI TRONG KHOA
    In Vivo September 2017, 31 (5) 957-960;
In Vivo

© 2026 In Vivo

Powered by HighWire